Gene Query: NAT8L

Dataset Description Geneva Score
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 50.36
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 39.23
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 36.43
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 33.26
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 31.8
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 31.69
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 29.73
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 29.7
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 29.7
Transcriptional profiling of microglia; current state of the art and future perspectives 29.32
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 29.32
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 27.09
circRNA-sequencing 24.63
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 24.43
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 23.52
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 21.81
Gene expression profiling of leukemia cells following asparagine depletion 21.32
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 21.28
Dtx3L and Androgen Signaling in Prostate Cancer 20.55
Gene expression profiling of papillary thyroid cancer from central and invasive regions 20.16
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 20.06
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 19.38
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 18.66
DJ-1 is dispensable for human stem cell homeostasis 18.66
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 18.23
The RNA-binding profile of Acinus, a peripheral component of the Exon junction complex, reveals its role in splicing regulation 17.92
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 17.91
Gene expression analysis of dengue-infected cells 17.54
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 17.42
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 17.29
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 16.75
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 16.55
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 16.55
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 16.49
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 16.24
DART-seq: an antibody-free method for global m6A detection 15.96
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 15.92
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 15.76
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 14.98
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 14.94
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 14.74
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 14.58
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 14.22
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 14.05
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 13.94
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 13.88
Effect of disulfiram treatment on pediatric high grade glioma 13.87
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 13.72
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 13.72
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 13.57
Transcriptome analysis of SKI knock-out in HL60 cells 13.44
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 13.44
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 13.42
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 13.26
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 12.71
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 12.71
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 12.61
Comparative Analysis of Cas9 Activators Across Multiple Species 12.35
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 12.05
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 11.74
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 11.71
Global gene expression profile of dasatinib-resistant RCH-ACV cells 11.55
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 11.55
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 11.29
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 11.11
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 11.03
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 10.96
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 10.94
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 10.93
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 10.87
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 10.77
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 10.75
Chromatin-informed inference of transcriptional programs in gynecologic cancers 10.75
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 10.73
Pharmacologic inhibition of STAT5 in AML 10.66
Global analysis of alternative splicing regulated by RBM10 10.61
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 10.29
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 10.28
Genome wide expression change by RNF168 knocking down in MCF-7 cells 10.19
Role of FGFR1 in neuronal devlopment 9.93
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 9.93
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 9.83
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 9.81
Glioblastoma stem cells infected by ZIKA virus 9.6
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 9.5
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 9.36
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 9.34
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 9.18
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 9.14
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 9.02
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 9.02
RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas 8.78
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 8.72
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 8.72
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 8.71
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 8.66
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 8.64
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 8.63
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 8.63
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 8.6
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 8.6
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 8.53
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 8.53
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 8.49
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 8.49
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 8.43
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 8.26
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription 8.22
PTEN interacts with the transcription machinery on chromatin and regulates RNA polymerase II-mediated transcription.[RNA-seq and ChIP-seq] 8.22
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 8.17
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 8.17
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 8.09
R430: A potent inbibitor of DNA and RNA viruses 8.06
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 7.98
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 7.98
The landscape of alternative splicing in aggressive prostate cancers 7.94
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 7.92
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 7.88
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 7.88
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 7.83
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 7.8
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 7.8
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 7.78
Crizotinib v. DMSO in SW480 cells 7.76
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 7.76
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 7.7
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) 7.58
BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage 7.58
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 7.55
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 7.49
Novel Targeting of Transcription and Metabolism in Glioblastoma 7.47
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 7.41
Universal alternative splicing of noncoding exons 7.39
Next Generation Sequencing Facilitates Quantitative Analysis of Human Pluripotent Stem Cell-Derived Endocardial-like And Primary Cardiac Endothelial Cell Transcriptomes 7.36
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 7.34
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 7.3
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 7.29
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 7.25
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 7.24
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 7.24
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 7.19
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 7.16
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 7.16
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 7.16
Alteration of the microRNA network during the progression of Alzheimer’s disease 7.15
Co-regulation of splicing by Rbfox1 and hnRNP M 7.12
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 7.12
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 7.11
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 7.11
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 7.07
Maturation of human iNSCs 7.0
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 6.96
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 6.95
Functional role of SLIT2 and ROBO1 in trophoblasts 6.95
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 6.84
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 6.84
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 6.81
FOXP1 orchestration of ASD-relevant signaling pathways. 6.8
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 6.79
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 6.77
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 6.75
Altering cancer transcriptomes using epigenomic inhibitors 6.75
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 6.74
RNA-seq of cancer cell lines treated with T-025 6.7
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 6.66
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 6.61
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 6.58
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 6.58
RNA-seq analysis of AML cells in response to ASLAN003 6.57
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 6.52
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 6.39
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 6.39
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 6.36
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 6.36
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 6.28
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 6.26
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 6.19
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 6.19
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 6.13
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 6.13
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 6.13
Total RNA sequencing of APC mutant and wt colonic organoids 6.12
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 6.11
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 6.1
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 6.08
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 6.08
Repurposing of promoters and enhancers during mammalian evolution 6.07
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 6.04
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 6.04
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 6.03
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 6.01
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 6.0
Functional astrocytes differentiated from hiPSCs 5.97
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 5.96
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 5.94
Subtle asymmetry of gene expression in embryonic and foetal human brains 5.93
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 5.9
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 5.9
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 5.88
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 5.88
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 5.84
Differential responses of human fetal brain neural stem cells to Zika virus infection 5.84
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 5.71
The MEF2B Regulatory Network - RNA-seq data 5.7
The MEF2B Regulatory Network 5.7
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 5.66
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 5.57
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 5.56
EP400 is required for Max and MCPyV mediated gene activation 5.49
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 5.46
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 5.46
Gene Expression Profiling of SPOP Knocked Down Cell 5.44
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 5.44
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 5.43
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 5.43
Genetic-to-epigenetic Therapy for Pancreatic Cancer 5.41
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 5.41
The effect of insulin on mRNA transcription of human pluripotent stem cells 5.38
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 5.35
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 5.34
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 5.31
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 5.24
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 5.24
Gene profiling of human adult and pediatric liver cancer cells 5.2
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 5.2
Epigenomic landscape during organ formation in human early embryos 5.2
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 5.16
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 5.15
SUV420H2 knockdown in PANC-1 5.15
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 5.13
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 5.11
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 5.08
Silencing p300 in MCF7 cells to study expression and alternative splicing 5.0
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 4.99
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 4.95
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 4.93
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 4.93
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 4.93
Gene expression changes in human melanoma cell lines compared to primary melanocytes 4.9
Chromatin landscape of human visceral and subcutaneous adipocytes 4.87
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 4.87
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 4.87
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 4.84
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 4.81
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 4.79
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 4.76
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 4.75
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 4.73
RNA Seq analysis of NKX2-5 Null and Het human embryonic stem cells in cardiomyogenesis 4.73
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 4.71
The Glioma-Infiltrating T Cell Receptor Repertoire 4.69
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 4.69
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 4.69
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 4.67
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 4.61
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 4.61
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 4.6
LNCaP treated with iBET 4.59
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 4.56
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 4.55
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 4.53
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 4.53
WRN knockout effects upon gene expression in SW48 and OVK18 4.52
Control of prostate tumour growth by the long non-coding RNA GHSROS 4.51
A map of gene expression in neutrophil-like cell lines 4.46
RNA-seq analysis of control and Myc-induced U2OS cells 4.45
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 4.45
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 4.36
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 4.35
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 4.35
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 4.34
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 4.34
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 4.32
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 4.28
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 4.18
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 4.16
Targeting MTHFD2 in Acute Myeloid Leukemia 4.09
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 4.03
Expression charcaterization of an internal protocol developed to differentiate RPE cells 4.02
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 3.96
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 3.95
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 3.94
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 3.94
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 3.93
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 3.93
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 3.87
Genome-wide identification of cancer-specific alternative splicing in circRNA 3.83
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 3.83
RNA splicing alteration on glioblastoma and normal neural stem cells 3.8
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 3.79
Functional Haploid Human Oocytes Generated from Polar Body Genomes 3.79
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 3.79
A transcriptome-wide divergence in protein translation scales with LIN28B expression 3.77
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 3.76
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 3.76
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 3.75
HNRNPM-regulated splicing dependencies in prostate cancer 3.71
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 3.71
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 3.71
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 3.71
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 3.7
Effect of ILF3 on translation during homeostasis and the antiviral response 3.68
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 3.59
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 3.57
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 3.57
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 3.52
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 3.48
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 3.48
A transcriptome dataset revealing the molecular features of breast cancer stem cells 3.46
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 3.42
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 3.41
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 3.4
Total RNA sequencing of WT intestinal orgaonids. 3.37
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 3.28
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 3.28
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 3.2
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 3.2
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 3.1
iPSC derived motor neuron cultures from C9ORF72 carriers 3.08
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 3.06
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 3.05
Identification of long noncoding RNAs in T-ALL cell lines 3.04
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 2.95
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 2.95
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 2.94
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 2.94
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 2.93
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 2.88
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 2.84
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 2.84
Induced DNA demethylation, genome instability and transcription 2.84
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 2.83
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.77
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.77
Functional significance of the HIV-1 Tat signature amino acid residues 2.75
NHLRC1 re-expression in cancer cells 2.74
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 2.71
circRNA profile in hypopharyngeal cancer 2.69
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 2.67
Gene Expression Signature in Adipose Tissue of Acromegaly Patients 2.66
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 2.63
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 2.63
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 2.63
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 2.62
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 2.61
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 2.6
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 2.6
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 2.57
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 2.56
JAK dependent survival of ALK- ALCL 2.52
Disruption of GRIN2B impairs differentiation in human neurons 2.51
Human ovarian granulosa cell transcriptome 2.51
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 2.49
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 2.47
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 2.44
Transcriptional dependencies in diffuse intrinsic pontine glioma 2.42
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 2.4
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 2.36
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 2.36
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 2.35
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 2.34
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 2.33
Interferon receptor signaling pathways regulating PD-L1 and PD-L2 expression 2.33
Gene expression profile in breast cancer cell lines using RNA sequencing 2.27
TAF1 is critical for AE driven leukemogenesis 2.23
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 2.23
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 2.2
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 2.19
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 2.17
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 2.14
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 2.11
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 2.11
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 2.1
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.09
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.09
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 2.09
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 2.08
LIN28A modulates splicing and gene expression programs in breast cancer cells 2.08
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 2.07
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 2.02
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 2.02
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 1.99
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 1.98
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 1.91
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 1.89
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 1.86
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 1.86
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 1.84
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 1.84
Epigenomic conservation of transposable element silencing [RNA-seq] 1.77
Epigenomic conservation of transposable element silencing 1.77
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 1.74
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 1.73
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 1.73
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 1.73
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 1.68
Transcriptome of human white and brown adipose tissue biopsies 1.66
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 1.62
Dissecting neural differentiation regulatory networks through epigenetic footprinting 1.6
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 1.6
Engineering Patient-Specific Tissue Implants 1.57
N6-methyladenine DNA Modification in Glioblastoma 1.56
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 1.56
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.52
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.45
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.45
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.43
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 1.43
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors [RNA-seq 2] 1.41
Activity-dependent transcriptional changes in human neurons 1.35
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.35
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 1.33
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 1.33
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 1.31
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 1.31
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.27
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 1.18
Hepatosplenic T cell lymphoma 1.18
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.14
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 1.14
SF3B1 Degron knockdown RNA-seq 1.1
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 1.07
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 1.02
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 1.0
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 0.99
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 0.99
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.98
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 0.94
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 0.94
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.93
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.93
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 0.92
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.87
Gene expression changes upon drug withdrawal (Mel888 cell line) 0.85
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 0.84
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 0.84
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.83
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 0.81
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.81
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 0.78
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 0.73
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.68
Gene expression analysis upon mtDNA depletion 0.68
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.68
HEK293 TFAM Knockout Expression Study 0.67
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 0.67
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 0.65
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.64
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.63
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.6
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 0.59
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.52
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 0.51
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 0.49
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 0.48
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 0.48
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 0.45
RNA-Seq and expression data from human adipose tissue 0.45
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.45
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 0.45
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.45
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.45
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.44
Multiple sclerosis and EAE 0.43
Human optic chiasm from healthy controls and multiple sclerosis patients 0.43
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.42
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 0.4
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.36
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.36
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.35
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.34
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.33
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 0.33
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 0.33
Transcriptome analyses of human pancreatic islets and pseudoislets 0.33
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.29
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.29
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.28
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 0.28
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.27
hNSCs siRNA NOVA2 0.25
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.23
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 0.22
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.21
RNA expression analysis upon JMJD1C depletion 0.21
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 0.21
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 0.19
The age and genomic integrity of neurons after cortical stroke in humans 0.18
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.14
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.14
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 0.13
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 0.09
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 0.09
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 0.07
RNA Seq data: A375, A375R, A375DR vorinostat treated, and biopy samples from patients pre- and post- treated with Vorinostat 0.07
An acquired vulnerability of drug resistant melanoma with therapeutic potential 0.07
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 0.03
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 0.03
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.01
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation